Buy & Sell MINISO Group Holding Ltd (MNSO) – MINISO Group Holding Ltd Price Today
Aura AI Summary
Key Stats
- $4.29BMarket Cap
- TechnologySector
- -27.57%3M Drawdown
- $4.77BEnterprise Value
- 4.72%Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 10 daysTypical Hold Time
MINISO Group Holding Ltd (MNSO) is currently valued at a market capitalization of $4.29B, with an enterprise value of $4.77B. Over the past 52 weeks, MINISO Group Holding Ltd has traded between a low of $13.85 and a high of $26.63, highlighting its annual price range. Over the past three months, MINISO Group Holding Ltd has recorded a drawdown of -27.57%, reflecting recent price volatility. MINISO Group Holding Ltd offers a dividend yield of 4.72%, with the most recent dividend of $0.38 paid on 20 Apr 26. On average, investors hold MINISO Group Holding Ltd for approximately 10 days, indicating typical investor behavior on the platform.
About MINISO Group Holding Ltd
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Most Recent News
BC launches Outdoor Sector Coalition to boost economy, health, and conservation of its outdoors.
A coalition of over 2,000 organizations in British Columbia has formed to support the province's outdoor sector, which is a $17 billion industry employing 80,000 people. The coalition aims to enhance health benefits, support outdoor businesses, and p...

Nvidia's Q1 2027 earnings face high expectations amid strong past beats but mixed stock reactions.
Nvidia is set to report its Q1 2027 earnings with Wall Street expecting $78.8 billion in revenue and $1.77 EPS, marking record growth. Historically, Nvidia has consistently beaten revenue and EPS estimates, but recent earnings have shown that the sto...

ESR1-mutated metastatic breast cancer market to grow 9.6% CAGR with new oral SERDs and targeted therapies.
The ESR1-mutated metastatic breast cancer market is projected to grow rapidly at a 9.6% CAGR from 2026 to 2036, driven by rising cases of endocrine-resistant HR-positive/HER2-negative breast cancer and advances in precision oncology. Novel therapies ...
